Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Healing Touch in Treating Fatigue in Women Undergoing Radiation Therapy for Breast Cancer [NA]
Completed clinical trial evaluating Healing Touch to treat fatigue in women undergoing radiation therapy for breast cancer; results were pos…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Imaging HSP90 Inhibitor AUY922 on VEGF-89ZR-bevacizumab Positron Emission Tomography (PET)
Clinical trial update reporting completion of an imaging study using AUY922, an HSP90 inhibitor, with VEGF-89Zr-bevacizumab PET in breast ca…
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery [Phase 2]
Phase 2 clinical trial evaluating erlotinib for breast cancer that can be removed by surgery has completed; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole [Phase 3]
Phase 3 results from the BOLERO-2 trial show that adding everolimus to exemestane improved progression-free survival in postmenopausal women…
-
CLINICAL_TRIALS trial_result · 2012-08-30Clinical Trial Update: Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases [Phase 2]
Phase 2 trial evaluating the efficacy of everolimus (RAD001) in breast cancer patients with bone metastases. The update indicates a Phase 2 …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer [Phase 2]
Phase 2 trial evaluating letrozole in combination with lapatinib as neoadjuvant therapy for early breast cancer; results were posted in 2012…
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue [Phase 2]
A Phase 2 trial evaluating ALC for breast cancer with fatigue was terminated.
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer [Phase 2]
Phase 2 trial evaluating primary chemotherapy regimens (docetaxel-capecitabine and doxorubicin-cyclophosphamide) in breast cancer has comple…
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: Efficacy and Safety Study of LEP-ETU to Treat Metastatic Breast Cancer [Phase 2]
The completed Phase 2 trial reports on the efficacy and safety of LEP-ETU for metastatic breast cancer, sponsored by INSYS Therapeutics.
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 pilot study evaluating docetaxel with bevacizumab, with or without trastuzumab, as first-line therapy for metastatic breast cancer…
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug [Phase 2]
Phase 2 study using [F-18]RGD-K5 PET to monitor response to an anti-angiogenic cancer therapy has completed, with enrollment spanning metast…
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer [Phase 2]
This Phase 2 trial assesses a dose-dense regimen of carboplatin, docetaxel, and trastuzumab as initial systemic therapy for breast cancer.
-
CLINICAL_TRIALS trial_result · 2012-08-17Clinical Trial Update: Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain [NA]
This clinical trial update reports completion and results posting for an 8-week duloxetine therapy study in breast cancer patients experienc…
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer [Phase 2]
Phase 2 trial evaluating the anti-tumor activity and tolerability of faslodex alone or in combination with arimidex in postmenopausal women …
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: Acupuncture for the Treatment of Chronic Lymphedema [Phase 2]
Phase 2 clinical trial evaluating acupuncture for chronic lymphedema in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer [Phase 1, Phase 2]
Phase 1/Phase 2 trial of Oblimersen with doxorubicin and docetaxel in metastatic or locally advanced breast cancer; study terminated with re…
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: Trastuzumab and External Beam Radiation Therapy in Treating Women With Stage III or Stage IV Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of trastuzumab with external beam radiation therapy in women with stage III or stage IV br…
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: Validity of Sentinel Lymphnode Biopsy After Neoadjuvant Chemotherapy Cancer Patients With Radiologically Positive Axillary Lymph Nodes
A completed trial evaluating the validity of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with radiol…
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating trastuzumab plus docetaxel in women with recurrent or metastatic breast cancer has completed enrollment. The stud…
-
CLINICAL_TRIALS trial_result · 2012-08-10Clinical Trial Update: Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast Cancer [Phase 2, Phase 3]
This clinical trial update examines the efficacy and safety of Xeloda (capecitabine) as sequential adjuvant therapy after chemotherapy in br…
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing [NA]
This clinical trial update documents that a study evaluating counseling interventions for BRCA1/2 cancer susceptibility testing has complete…
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer
A randomized study evaluating Water-Jel Aloe Vera Gel (R1/R2) for prevention of radiation dermatitis in breast cancer patients has been term…
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating the combination of Abraxane and cisplatin in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer [Phase 2]
This clinical trial update describes a Phase 2 presurgical study in primary breast cancer evaluating molecular predictors of lapatinib's eff…
-
CLINICAL_TRIALS trial_result · 2012-08-03Clinical Trial Update: Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast Cancer [Phase 2, Phase 3]
A Phase 2/3 trial evaluating TAC (docetaxel, doxorubicin, cyclophosphamide) versus exemestane as neoadjuvant chemotherapy in postmenopausal …